Every big technology and treatment that scientists, like Dr. Aaron Ward, have for any disease at some point begins in a lab. But it has to start somewhere and it starts with donors. You help define the landscape of care.

Donate today: bit.ly/4bEsCrO

The 2024 conference programme will launch shortly, and registration will open.
Our headline speakers include Dr David Palma, Professor Shankar Siva and Professor Marcel van Herk. Exciting times await in Edinburgh. Dr. David Palma Shankar Siva

#ESTRO2024 in Glasgow, Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿

Presented a systematic review and meta-analysis of #SABR in oligoprogression ☢️

12 years after we launched ORATOR, what did we learn?
Three summary slides 👇👇👇

Some new ORATOR data coming today at #ESTRO24 !

- Final results of ORATOR, after completion of 5 years of follow-up (clinical trials session @ 11:40)

- Primary analysis of ORATOR2 for de-escalation (LBA session @ 16:35)

Come join if you are interested!

I think Dr. David Palma (in his outstanding lecture on novel #ReIrradiation dose finding trial design) might inadvertently have explained my fascination with reirradiation … 😉
#ESTRO24 #radonc #medphys

Huge endeavour by ESTRO ESMO - Eur. Oncology to create guidelines for combination of #radiotherapy & new cancer drugs.

Looking forward to full paper. As Dr. David Palma discussed, the toxicity threshold to withhold #radiotherapy (or lower dose) needs to be defined on case by case basis.

Wich type of re-irradiation? Minivan or F1?

Dr. David Palma #ESTRO24

Are you a #radonc resident looking for a fellowship in either SABR/SRS for oligomets, or brachytherapy?

Check out these 2 new fellowships: the Verspeeten Family Fellowships in London, Canada. LHSF Canada ACROresident CARO Residents & Fellows

caro-acro.ca/careers-develo…

ICYMI: Monday marked a historical moment in redefining cancer care at London Health Sciences Centre. With the official unveiling of the Verspeeten Family Cancer Centre, made possible by Archie and Irene Verspeeten, we've taken a giant leap forward in advancing cancer research, care and hope.

Today we celebrate a monumental donation from the Verspeeten family to fund the future of cancer care and research.

In rad onc, the funds will support annual fellowships in SABR and brachy, starting in 2025!

LHSF Canada

Really enjoyed our visit by Sue Yom…showing off her precision targeting skills here.

Thank you Sue Yom for coming to Schulich WesternU to visit!

We really enjoyed your talks on de-escalation in head and neck cancers and scientific publishing! #radonc

Also axe throwing was such a blast! 🪓

Dr. David Palma CTCR

Diagnostic CT-Enabled Planning (DART) for palliative RT
👉 Time in center reduced from 4.7h to 0.4h
👉 Highly relevant study to reduce efforts for palliative patients while maintaining radiotherapy quality
👏 Melissa O'Neil Dr. David Palma and study team
redjournal.org/article/S0360-…

If you are interested in the SUNSET paper, we added 2 dose distributions that might be helpful: one that illustrates where the PTV needed to be compromised, and one where it didn't.

A full dosimetry paper is coming later...